Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?
Carlos Solano de la Asunción, Rafael Hernani, Eliseo Albert, María Dolores Gómez, Estela Giménez, Ana Benzaquén, Eva María Gonzalez‐Barberá, Juan Carlos Hernández‐Boluda, Ariadna Pérez, José Luís Piñana, Pedro Chorão, Manuel Guerreiro, Juan Montoro, Jaime Sanz, Carlos Solano, David Navarro
Topics & Concepts
MedicineCytomegalovirusChimeric antigen receptorCD19VirologyAntigenCoronavirus disease 2019 (COVID-19)ImmunologyHuman cytomegalovirusRetrospective cohort studyInternal medicineHerpesviridaeVirusViral diseaseT cellDiseaseImmune systemInfectious disease (medical specialty)CAR-T cell therapy researchCytomegalovirus and herpesvirus researchVirus-based gene therapy research